Learn how CHRISTUS Health is keeping you and your family's health our #1 priority amid the spread of the COVID-19 Delta variant. Learn More

COVID 19 Research News

Hyperbaric oxygen therapy for wound care being used to treat some COVID-19 patients

SHREVEPORT, La. — Christus Health is trying something new to treat COVID-19 by using hyperbaric oxygen therapy to sustain a COVID-19 patient through oxygen deficiency. Hyperbaric oxygen therapy isn’t new but, using it for this purpose is. Christus Health Shreveport-Bossier is the only facility in the region to try it. It started using the treatment in early May.


Philip Ortego and Natasha So’oto are engaged to be married. In May of last year, when Philip asked Natasha to marry him in the mountains of Tennessee this Northern Louisiana couple had no idea how much could change in a year. In late March and most of April they were forced to spend time away from each other. They spent 3 weeks in solitude from one another after they both tested positive for COVID-19. Thankfully, their cases were mild and they recovered while at home and in quarantine.

Christus St. Vincent tries new plasma treatment for COVID-19

Could injecting the plasma of someone who has recovered from COVID-19 treat someone who is still in the throes of the disease?

That’s the hope of doctors at Christus St. Vincent Regional Medical Center in Santa Fe, where what could be the state’s first plasma transfusion for the disease was administered at 10 p.m. Monday in cooperation with a national program led by the Mayo Clinic to expand access to the experimental treatment.

HBO Treatment

During HBO treatment, a patient is placed in a sealed single- or multi-person chamber, where high levels of oxygen are delivered to the lungs, and then absorbed into the bloodstream under pressure. This is very similar to what happens when a scuba diver breathes oxygen from a tank at depth—more oxygen enters the tissues. And HBO has been found over the years to advance healing and successfully treat a variety of conditions, including burns, soft-tissue infections, and chronic wounds. It has a long track record of safety.


Interview with Pukar Ratti

Alexandria's KALB interviews, Pukar Ratti, Regional Research Director, regarding developing a vaccine for COVID-19